2005-004754-27: Comparison of insulin detemir and insulin glargine in patients with Type 2 diabetes |
|
|
| Ongoing | 2 | 12 | Europe | insulin glargine, insulin detemir, Lantus 100 IU/ml, Levemir 100 U/ml, Lantus 100 IU/ml, Levemir 100 U/ml | Cardiff University | Type 2 Diabetes | | | | |
2015-004723-31: Study to assess the efficacy of treatment of autoimmune diabetes of adults (LADA) with metformin / dapagliflozin / saxagliptin against metformin / insulin glargine (LADA) Studio per valutare l'efficacia della terapia del diabete autoimmune dell'adulto (LADA) con metformina/dapagliflozin/saxagliptin contro metformina/insulina glargine |
|
|
| Not yet recruiting | 2 | 100 | Europe | ONGLYZA, FORXIGA, metformina, LANTUS, 039453016, Film-coated tablet, Coated tablet, Solution for injection, ONGLYZA - 5 MG-COMPRESSE RIVESTITE CON FILM -USO ORALE-BLISTER NON PERFORATO(ALU/ALU) 28 COMPRESSE, FORXIGA - 10 MG - COMPRESSE RIVESTITE CON FILM- USO ORALE - BLISTER CALENDARIZZATO (ALU/ALU) - 28 COMPRESSE, LANTUS - 100 IU/ML OPTISET SOLUZIONE INIETTABILE CARTUCCE IN 5 PENNE MONOUSO 3 ML USO SOTTOCUTANEO | UNIVERSITÀ CAMPUS BIO-MEDICO DI ROMA, Astra Zeneca S.p.A. | LADA Diabete autoimmune dell'adulto LADA, autoimmune diabetes of adults diabete autoimmune dell'adulto, Diseases [C] - Hormonal diseases [C19] | | | | |
NCT04591457: The Efficacy, Safety, and Immunogenicity Study Comparing an Insulin Glargine Biosimilar Sansulin Log-G to Lantus |
|
|
| Not yet recruiting | 2 | 120 | RoW | Insulin Glargine Sansulin, Sansulin, Insulin Glargine Pen Injector [Lantus], Lantus | Indonesia University | Diabetes Mellitus | 08/21 | 08/21 | | |
NCT06007508: Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis |
|
|
| Terminated | 2 | 8 | US | Insulin Glargine, Lantus, Basaglar, Semglee | HealthPartners Institute | DKA | 02/23 | 02/23 | | |
